BioCardia, Inc.
NASDAQ: BCDA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter A. Altman
- Employees
- 17
- Headquarters
- Sunnyvale, United States
- IPO year
- 1996
- Market cap
- $6.1M
- Website
- https://www.biocardia.com
Loading BCDA…
Loading profile data…Frequently asked questions about BCDA
What does BioCardia, Inc. (BCDA) do?
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Add...
Where does BCDA trade?
BioCardia, Inc. (BCDA) trades on the NASDAQ Capital Market.
What sector is BCDA in?
BioCardia, Inc. (BCDA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BioCardia, Inc.?
Peter A. Altman is the chief executive officer of BioCardia, Inc. (BCDA).
Where is BioCardia, Inc. headquartered?
BioCardia, Inc. is headquartered in United States.
Does BCDA pay a dividend?
BioCardia, Inc. (BCDA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BCDA go public?
BioCardia, Inc. (BCDA) completed its initial public offering in 1996.